Insmed Incorporated (INSM)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.12B |
| Enterprise Value | 2.88B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 16.41 |
| Price/Book (mrq) | 6.19 |
| Enterprise Value/Revenue | 16.57 |
| Enterprise Value/EBITDA | -7.66 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.16 |
| 52-Week Change 3 | -49.98% |
| S&P500 52-Week Change 3 | 16.27% |
| 52 Week High 3 | 45.44 |
| 52 Week Low 3 | 21.59 |
| 50-Day Moving Average 3 | 27.55 |
| 200-Day Moving Average 3 | 27.81 |
Share Statistics
| Avg Vol (3 month) 3 | 752.27k |
| Avg Vol (10 day) 3 | 827.33k |
| Shares Outstanding 5 | 118.37M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 110.96M |
| % Held by Insiders 1 | 1.51% |
| % Held by Institutions 1 | 105.54% |
| Shares Short (Dec. 30, 2021) 4 | 7.07M |
| Short Ratio (Dec. 30, 2021) 4 | 10.21 |
| Short % of Float (Dec. 30, 2021) 4 | 7.47% |
| Short % of Shares Outstanding (Dec. 30, 2021) 4 | 5.98% |
| Shares Short (prior month Nov. 29, 2021) 4 | 7.15M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Mar. 02, 2011 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | -243.96% |
| Operating Margin (ttm) | -208.14% |
Management Effectiveness
| Return on Assets (ttm) | -21.00% |
| Return on Equity (ttm) | -98.36% |
Income Statement
| Revenue (ttm) | 173.75M |
| Revenue Per Share (ttm) | 1.61 |
| Quarterly Revenue Growth (yoy) | 7.10% |
| Gross Profit (ttm) | 33.86M |
| EBITDA | -354.69M |
| Net Income Avi to Common (ttm) | -423.89M |
| Diluted EPS (ttm) | -3.92 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 846.56M |
| Total Cash Per Share (mrq) | 7.15 |
| Total Debt (mrq) | 601.21M |
| Total Debt/Equity (mrq) | 119.09 |
| Current Ratio (mrq) | 8.52 |
| Book Value Per Share (mrq) | 4.26 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -345.96M |
| Levered Free Cash Flow (ttm) | -171.66M |
